Campbell & Co Investment Adviser’s BioLife Solutions BLFS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Buy	+13,589	New	+$318K	0.02%	843
2026 Q1	–	Sell	-21,820	Closed	-$528K	–	1088
2025 Q4	$528K	Sell	21,820 -12,713	-37%	-$333K	0.03%	805
2025 Q3	$881K	Buy	34,533 +21,277	+161%	+$505K	0.07%	470
2025 Q2	$286K	Buy	+13,256	New	+$299K	0.02%	973
2024 Q1	–	Sell	-14,680	Closed	-$239K	–	1116
2023 Q4	$239K	Buy	+14,680	New	+$187K	0.02%	995
2022 Q2	–	Sell	-14,379	Closed	-$327K	–	688
2022 Q1	$327K	Buy	+14,379	New	+$379K	0.09%	449

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Campbell & Co Investment Adviser's BLFS Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in BioLife Solutions (BLFS) in Q2 2026: 13,589 shares worth $384K. The stake represents 0.02% of the portfolio and ranks #843 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in BLFS as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in BLFS in Q1 2022 and has held it in 6 quarters since. The position peaked at $881K in Q3 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Campbell & Co Investment Adviser held 13,589 shares of BioLife Solutions worth $384K as of Q2 2026.
BioLife Solutions was a new Campbell & Co Investment Adviser position in Q2 2026.
BioLife Solutions made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #843 holding.
Campbell & Co Investment Adviser first reported a position in BioLife Solutions in Q1 2022 and has held it in 6 quarters since.
Campbell & Co Investment Adviser's BioLife Solutions position peaked at $881K in Q3 2025.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.